SurgoCap Partners LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001960830

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidFocusedTechnology TiltHigh Turnover how tags are computed

Q3 2024 · 11 positions · Total reported value $1.70B · Top-10 concentration 94.4% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 56.2% · 3 new · 1 cut · 5 exited

Active Share (vs S&P 500): 92.4% · vs QQQ: 91.3% — share of the book that differs from index weights (higher = more active) · ranking

In its Q3 2024 13F filing, SurgoCap Partners LP disclosed 11 equity positions with a combined reported value of $1.70B. The filing implies a focused portfolio: its ten largest positions account for 94.4% of reported value. HoldingsHub classifies the profile as Mid / Focused / Technology Tilt / High Turnover.

The largest disclosed positions as of Q3 2024 were MCK ($300.76M), LPLA ($181.62M), META ($173.93M). By sector, the heaviest allocations are Technology 43.2%, Health Care 27.1%. Versus the prior quarter, allocation shifted toward Industrials (+6.2pp), Health Care (+5.4pp) and away from Consumer Discretionary (-5.9pp), Technology (-7.0pp).

Versus the prior quarter, SurgoCap Partners LP opened 3 new positions, trimmed 1 and fully exited 5, a turnover rate of 56.2% of positions. The portfolio's overlap with the prior quarter was 60% of names.

The largest new positions opened in Q3 2024 were META ($173.93M), CRS ($105.76M).

Of the 5 positions fully exited versus the prior quarter, the largest were QCOM ($124.31M), NVDA ($105.95M), CNM ($101.56M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2024)

  • META META PLATFORMS INC · $173.93M
  • CRS CARPENTER TECHNOLOGY CORP · $105.76M

Fully Exited (vs previous quarter)

  • QCOM QUALCOMM INC · prev qtr: $124.31M
  • NVDA NVIDIA CORPORATION · prev qtr: $105.95M
  • CNM CORE & MAIN INC · prev qtr: $101.56M
  • MSFT MICROSOFT CORP · prev qtr: $87.35M · history

Insider Transactions (Form 4)

Latest SurgoCap Partners LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

SurgoCap Partners LP, based in New York, NY, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 13 positions worth $3.09B in total. HoldingsHub carries 11 quarters of its filings (Q4 2023–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-126914 (status: Approved), registered 2022-12-07
  • Regulatory AUM (Form ADV): $7.35B as of 2026-06-26
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 2 private funds, of which 1 hedge funds
  • Website: surgocap.com

Portfolio Structure

  • 13 positions · $3.09B reported value (Q2 2026)
  • Top 10 holdings = 92.2% of reported value
  • Largest position: TSM (TAIWAN SEMICONDUCTOR MANUFAC) at 14.0%
  • Average position size: $237.96M

Sector Tilt

  • Information Technology 33.4%
  • Health Care 22.1%
  • Industrials 20.3%
  • (classified holdings cover 99% of value)

Quarterly Activity

  • Q2 2026: 3 new, 4 added, 6 reduced, 4 exited

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Technology 43.2%
Health Care 27.1%
Financials 23.5%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 608.32K $300.76M 17.67%
17.67%
Add
2 780.72K $181.62M 10.67%
10.67%
Add
3 303.84K $173.93M 10.22%
10.22%
New
4 711.71K $165.83M 9.74%
9.74%
Add
5 1.71M $160.31M 9.42%
9.42%
Add
6 282.11K $142.86M 8.39%
8.39%
Add
7 500.00K $127.49M 7.49%
7.49%
Reduce
8 687.29K $125.73M 7.38%
7.38%
Reduce
9 800.54K $122.59M 7.20%
7.20%
Reduce
10 662.71K $105.76M 6.21%
6.21%
New
11 7.00M $95.61M 5.62%
5.62%
Reduce

FAQ

What did SurgoCap Partners LP buy in 2024-Q3?

In its 2024-Q3 13F filing, SurgoCap Partners LP reported 11 equity positions worth $1.70B in aggregate; its largest disclosed positions were MCK ($300.76M), LPLA ($181.62M), META ($173.93M).

How large is SurgoCap Partners LP's portfolio?

SurgoCap Partners LP reported $1.70B of long equity holdings across 11 positions as of 2024-Q3. Top-10 holdings account for 94.4% of reported value.

What is SurgoCap Partners LP's investment style?

HoldingsHub classifies the portfolio as Mid / Focused / Technology Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/surgocap-partners/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →